Hepatitis Archives - Infectious Disease Advisor

Tri-Antigenic vs Mono-Antigenic Vaccine for Hepatitis B Virus Prevention

By

Rita Aghjayan

June 18, 2021

A team of researchers sought to compare the seroprotection rate of a hepatitis B virus tri-antigenic vaccine with that of a mono-antigenic vaccine in adults.

Hepatitis

Universal Screening for Hepatitis B Virus Offers Better Health Outcomes, Cost Savings

By

Sweta Gupta

June 18, 2021

Researchers assessed the cost-effectiveness of universal adult screening for chronic hepatitis B virus infection.

Hepatitis

Epclusa Approved for Younger Patients With Chronic Hepatitis C

By

Brian Park, PharmD

June 16, 2021

The expanded approval was based on data from an open-label phase 2 trial that evaluated Epclusa in 41 patients 3 years to less than 6 years of age with chronic HCV infection.

Hepatitis

Antiviral Therapy Reduces Cirrhosis Risk in Patients With Chronic HBV

By

Nikki Kean

June 15, 2021

The finding of a reduce risk of cirrhosis in patients with chronic HBV on antiviral therapy underscores the importance of early treatment.

Hepatitis

Improved Liver Function Following Eradication of Hepatitis C Virus Among Patients With Cirrhosis

By

Jessica Nye, PhD

June 14, 2021

Liver function changes were evaluated in HIV/HCV coinfected vs HCV monoinfected patients with cirrhosis who achieved HCV eradication following direct-acting antiviral therapy.

COVID19

COVID 19 Case Studies: Hepatitis. Peripheral Ischemia, and Pulmonary Embolism

By

Lauren Biscaldi

June 1, 2021

Novel presentations of COVID-19 include acute hepatitis, peripheral ischemia, and bilateral pulmonary embolism as described in these case studies.

Hepatitis

Gut Dysbiosis May Be Alleviated After DAA Treatment for Hepatitis C Virus Infection

By

Sweta Gupta

May 25, 2021

Researchers assessed the influence of direct-acting antivirals on gut microbiota by analyzing microbial diversity and composition in patients with hepatitis C virus infection with or without HIV.